Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 177.21M
December 31, 2024 260.65M
December 31, 2023 235.42M
December 31, 2022 293.09M
December 31, 2021 348.48M
December 31, 2020 224.70M
December 31, 2019 38.22M
Date Value
December 31, 2018 64.62M
December 31, 2017 16.90M
December 31, 2016 17.26M
December 31, 2015 29.89M
December 31, 2014 36.43M
December 31, 2013 5.128M
December 31, 2012 5.83M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Natera, Inc. 1.076B
Caris Life Sciences, Inc. 800.09M
Myriad Genetics, Inc. 149.60M
BioRestorative Therapies, Inc. 2.953M
Exagen, Inc. 32.22M